Simulations Plus Unveils ADMET Predictor® 11, Revolutionizing Drug Modeling and Simulation
 
In a groundbreaking move, Simulations Plus, Inc. (Nasdaq: SLP), a renowned leader in the field of modeling and simulation solutions for the pharmaceutical and biotechnology industries, has officially launched ADMET Predictor® 11. This cutting-edge version of their flagship machine learning modeling platform introduces an array of innovative features, models, and partner data that significantly enhance predictive accuracy.
 
ADMET Predictor® 11 boasts several game-changing advancements:
- Unprecedented inclusion of new industry partner data that more than doubles the number of ionization constants (pKa), resulting in superior predictive accuracy and broader applicability of their state-of-the-art S+pKa model.
- Revolutionary functionality to conduct 3D virtual screening based on shape and pharmacophore-feature similarity, providing researchers with unparalleled insights into drug interactions.